Commonwealth Scientific and Industrial Research Organisation

Aortech International Plc

Other

Foldax, Inc.

Aertech International Plc

Mark Bown

Sriram Venkataramani

Mansour Mehrabi

Raju Adhikari

Kazunori Ueno

Pathiraja Arachchillage Gunatillake

Ajay D Padsalgikar

Ramasri Mudumba

Graeme Douglas Puxty

Alexander Bilyk

Qi Yang

Michelle Groarke

Ajay Padsalgikar

Mathew John Ballard

Gerhard Frederick Swiegers

Paul Feron

Sven Andresen

Moetaz Ibrahim Attalla

Susan N James

Andrew Wayne Allport

Robert Cameron Rowland

Anthony Wilson

Trang Thanh Nhan

Pathiraja A Gunatillake

John Kraft

Anton Launikonis

Peter Osvath

The present disclosure provides soft block copolymer segments of Formula 1 for thermoplastic polyurethane or polyurethaneurea elastomer materials and their reaction products with divalent compounds, such as diisocyanates, chain extenders and optional additional polyols or polyamines. Also disclosed herein are methods for the production of the soft block copolymer segments, and possible applications of these materials in the formation of biomaterials for articles including medical devices such as implants, heart valves and drug delivery devices.

Polyurethane/urea materials

A valve in the form of a medical device, article, or implant that is composed wholly or partly of a biomaterial, the biomaterial comprising a polyurethane or polyurethane urea elastomeric composition having a plurality of soft segments and hard segments, such that the plurality of soft segments are each derived from at least one block copolymer segment of Formula 1 and optionally an additional polyol or polyamine. The valve may include a plurality of valve leaflets and a support structure with one or more of the valve leaflets being composed wholly or partly of the biomaterial.

Polyurethane/urea compositions

The present invention relates to biostable gel comprising:

Gels

The present disclosure generally relates to diamine compounds, which may be used as precursors in preparing diazaborole compounds and phosphorescent diazaborole metal complexes. The present disclosure also relates to diazaborole compounds, diazaborole metal complexes, and electroluminescent emission materials and electronic devices thereof. The present disclosure further relates to processes for preparing the diamine compounds and diazaborole metal complexes.

Diamine compounds for phosphorescent diazaborole metal complexes and electroluminescent devices

The present disclosure generally relates to phenylenediamine compounds, which may be used as precursors in preparing diazaborole compounds and phosphorescent diazaborole metal complexes. The present disclosure also relates to diazaborole compounds, diazaborole metal complexes, and electroluminescent emission materials and electronic devices thereof. The present disclosure further relates to processes for preparing the phenylenediamine compounds and diazaborole metal complexes.

Phenylenediamine compounds for phosphorescent diazaborole metal complexes

Disclosed herein are phosphorescent materials comprising a complex of a metal atom M selected from Ir, Pt, Rh, Pd, Ru and Os and at least one ligand L, wherein the ligand L is represented by formula (1). Also disclosed are organic electroluminescent devices including such phosphorescent materials.

Electroluminescent devices based on phosphorescent iridium and related group VIII metal multicyclic compounds

A process for the capture of COfrom gas streams, the process including contacting a COcontaining gas stream with a compound including: a primary or non-sterically hindered secondary amine group and at least one tertiary amine or sterically hindered secondary amine group; wherein the primary or non-sterically hindered secondary amine and the nearest tertiary or sterically hindered secondary amine group are separated by a carbon chain including 3 or 4 carbon atoms and wherein the compound is a compound of Formula (I).

Gas capture process

A process for the capture of COfrom gas streams comprising contacting a COcontaining gas stream with an aqueous alkanolamine solution, wherein the alkanolamine is selected from the group consisting of: 3-piperidinemethanol, Tricine, 3-quinuclidinol, 3-piperidino-1,2-propanediol and their salts.

[object Object]

The present invention relates to silicon-containing biostable gels and processes for their preparation. The gels possess properties which make them useful in the manufacture and repair of biomaterials and medical devices, articles or implants, in particular the manufacture of soft tissue implants such as breast implants and the repair of orthopaedic joints such as spinal discs.

Growing community of inventors

Notting Hill, Australia

Mark Bown